(Q36140831)

12 August 2017

Inhibitory human antichimeric antibodies to rituximab in a patient with pemphigus (English)

1 reference

12 August 2017

1 reference

1 reference

Luisa Lunardon

1

1 reference

12 August 2017

Aimee S Payne

series ordinal

2

1 reference

12 August 2017

language of work or name

English

0 references

publication date

26 April 2012

1 reference

The Journal of Allergy and Clinical Immunology

12 August 2017

4

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

12 August 2017

130

1 reference

12 August 2017

3

1 reference

12 August 2017

800-803

1 reference

Serum sickness with an elevated level of human anti-chimeric antibody following treatment with rituximab in a child with chronic immune thrombocytopenic purpura.

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412073

Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412073

A single cycle of rituximab for the treatment of severe pemphigus.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412073

Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412073

Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412073

Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412073

Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412073

Immunogenicity of rituximab in patients with severe pemphigus

5 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22541247

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22541247

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.JACI.2012.03.022

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

22541247

1 reference